Treatment of non-metastatic castration-resistant prostate cancer
Benefits sustained only on surrogate endpoints
1 COMENTÁRIOS
Benefits sustained only on surrogate endpoints
1 COMENTÁRIOS
Therapeutic options and toxicity profile
0 COMENTÁRIOS
International cooperative effort
0 COMENTÁRIOS
Concerns about futility, obsolescence and uncertainties
0 COMENTÁRIOS